GUFICBIONSEGufic Biosciences Limited· PharmaceuticalsMediumPositive
Announced Fri, 29 May · 22:46 IST

Gufic Biosciences Limited has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 0.10 per equity share.

Corporate Actions View source PDF

GUFICBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+6.2%1-day move
₹332.15
prior close
₹342.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.2-1.7+2.0+6.2+9.0+6.0+12.1+13.5+9.3+7.8+18.9
Up moveDown movePending
AI summary

Gufic Biosciences Limited's Board of Directors has recommended a Final Dividend of Rs. 0.10 per equity share (10% on face value of Re. 1/-) for Financial Year 2025-26. The dividend is subject to approval by shareholders at the ensuing Annual General Meeting. If approved, the dividend will be paid within statutory timelines as per the Companies Act, 2013. The Board meeting was held on May 29, 2026, from 7:30 PM to 9:05 PM.

Likely market impact

The dividend of Re. 0.10 per share is a modest payout, indicating the company is sharing profits with shareholders. However, without knowing the current market price, the yield impact cannot be assessed. This is a routine shareholder-friendly move pending AGM approval.